Kim Jae-Seok, Jeong Hun-Jin, Park Ji-Woo, Gwak So-Jung, Han Jeong-Sun, Jung Kyoung In, Lee Seung-Jae
Department of Mechanical Engineering, Wonkwang University, 460 Iksandae-ro, Iksan 54538, Republic of Korea.
Regenerative Engineering Laboratory, Columbia University, 630W 168th ST, New York, NY 10032, USA.
Polymers (Basel). 2025 Jan 5;17(1):118. doi: 10.3390/polym17010118.
Glaucoma treatment involves reducing the intraocular pressure (IOP), which can damage the optic nerve, to a normal range. Aqueous drainage devices may be used for treatment, and a variety of devices have been proposed. However, they have a non-variable and uniform inner diameter, which makes it difficult to accommodate the IOP fluctuations that occur after glaucoma surgery. To ensure effective treatment in the early post-operative period with low IOP and the late post-operative period with high IOP, the inner diameter should be expandable over time to allow for smooth aqueous drainage. Here, we applied 3D printing technology with a tri-axial nozzle to develop an aqueous drainage tube that can expand its inner diameter. The distinct bilayer structure of the device allows it to expand its inner diameter through biodegradation, which can accommodate the IOP fluctuations that often occur after glaucoma surgery. The fabricated structure was evaluated in a series of tests, including leakage, cytotoxicity, and degradation experiments. The device did not show any leakage, was not toxic to cells, and demonstrated the expansion of the inner diameter through biodegradation. The device may provide a more effective post-operative solution for glaucoma patients by alleviating the effects of low IOP in the early post-operative period and high IOP in the late post-operative period.
青光眼治疗包括将可能损害视神经的眼内压(IOP)降低至正常范围。房水引流装置可用于治疗,并且已经提出了多种装置。然而,它们具有固定且均匀的内径,这使得难以适应青光眼手术后出现的眼内压波动。为确保在术后早期眼内压低和术后晚期眼内压高时都能有效治疗,内径应随时间可扩张,以实现顺畅的房水引流。在此,我们应用带有三轴喷嘴的3D打印技术来开发一种可扩张内径的房水引流管。该装置独特的双层结构使其能够通过生物降解来扩张内径,这可以适应青光眼手术后经常出现的眼内压波动。对制造的结构进行了一系列测试评估,包括渗漏、细胞毒性和降解实验。该装置未出现任何渗漏,对细胞无毒,并通过生物降解证明了内径的扩张。该装置可能通过减轻术后早期眼内压低和术后晚期眼内压高的影响,为青光眼患者提供更有效的术后解决方案。